Tissue-specific alterations in thyroid hormone homeostasis in combined Mct10 and Mct8 deficiency

Endocrinology

Volumn 155, Issue 1, 2014, Pages 315-325

  Müller, Julia ^a   Mayerl, Steffen ^a   Visser, Theo J ^b   Darras, Veerle M ^c   Boelen, Anita ^d   Frappart, Lucien ^a   Mariotta, Luca ^e   Verrey, Francois ^e   Heuer, Heike ^a,f  

^a FRITZ LIPMANN INSTITUTE   (Germany)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF ZURICH   (Switzerland)

^f IUF LEIBNIZ RESEARCH INSTITUTE FOR ENVIRONMENTAL MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; MONOCARBOXYLATE TRANSPORTER; MONOCARBOXYLATE TRANSPORTER 10; MONOCARBOXYLATE TRANSPORTER 8; PROLACTIN; PROTIRELIN; SODIUM IODIDE SYMPORTER; THYROID HORMONE; THYROID PEROXIDASE; THYROTROPIN; THYROTROPIN RECEPTOR; THYROXINE; THYROXINE I 125; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CELL TRANSPORT; COMPARATIVE STUDY; FEMALE; HISTOPATHOLOGY; HOMEOSTASIS AND REGULATION; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IN SITU HYBRIDIZATION; IN VIVO STUDY; KNOCKOUT MOUSE; LIOTHYRONINE BLOOD LEVEL; LIVER; MALE; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; PROGENY; PROTEIN DEFICIENCY; PROTO ONCOGENE; REAL TIME POLYMERASE CHAIN REACTION; THYROID FOLLICLE CELL; THYROID GLAND; THYROID HORMONE BLOOD LEVEL; THYROID HORMONE METABOLISM; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TISSUE LEVEL; TISSUE SPECIFICITY; UPREGULATION; X CHROMOSOME;

EID: 84891418244     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2013-1800     Document Type: Article

References (40)

1. Visser WE, Friesema EC, Jansen J, Visser TJ. Thyroid hormone transport in and out of cells. Trends Endocrinol Metab. 2008;19: 50-56.
2. Friesema EC, Ganguly S, Abdalla A, et al. Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter. J Biol Chem. 2003;278:40128-40135.
3. Dumitrescu AM, Liao XH, Best TB, Brockmann K, Refetoff S. A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene. Am J Hum Genet. 2004;74:168-175.
4. Friesema EC, Grueters A, Biebermann H, et al. Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation. Lancet. 2004;364:1435-1437.
5. Schwartz CE, May MM, Carpenter NJ, et al. Allan-Herndon-Dudley syndrome and the monocarboxylate transporter 8 (MCT8) gene. Am J Hum Genet. 2005;77:41-53.
6. Friesema EC, Jansen J, Heuer H, Trajkovic M, Bauer K, Visser TJ. Mechanisms of disease: psychomotor retardation and high T3 levels caused by mutations in monocarboxylate transporter 8. Nat Clin Pract Endocrinol Metab. 2006;2:512-523.
7. Dumitrescu AM, Liao XH, Weiss RE, Millen K, Refetoff S. Tissuespecific thyroid hormone deprivation and excess in monocarboxylate transporter (mct) 8-deficient mice. Endocrinology. 2006;147: 4036-4043.
8. Trajkovic M, Visser TJ, Mittag J, et al. Abnormal thyroid hormone metabolism in mice lacking the monocarboxylate transporter 8. J Clin Invest. 2007;117:627-635.
9. Ceballos A, Belinchon MM, Sanchez-Mendoza E, et al. Importance of monocarboxylate transporter 8 for the blood-brain barrier-dependent availability of 3,5,3-triiodo-L-thyronine. Endocrinology. 2009;150:2491-2496.
10. Wirth EK, Roth S, Blechschmidt C, et al. Neuronal 3,3,5-triiodothyronine (T3) uptake and behavioral phenotype of mice deficient in Mct8, the neuronal T3 transporter mutated in Allan-Herndon-Dudley syndrome. J Neurosci. 2009;29:9439-9449.
11. Sugiyama D, Kusuhara H, Taniguchi H, et al. Functional characterization of rat brain-specific organic anion transporter (Oatp14) at the blood-brain barrier: high affinity transporter for thyroxine. J Biol Chem. 2003;278:43489-43495.
12. Tohyama K, Kusuhara H, Sugiyama Y. Involvement of multispecific organic anion transporter, Oatp14 (Slc21a14), in the transport of thyroxine across the blood-brain barrier. Endocrinology. 2004;145: 4384-4391.
13. Ito K, Uchida Y, Ohtsuki S, et al. Quantitative membrane protein expression at the blood-brain barrier of adult and younger cynomolgus monkeys. J Pharm Sci. 2011;100:3939-3950.
14. Roberts LM, Woodford K, Zhou M, et al. Expression of the thyroid hormone transporters monocarboxylate transporter-8 (SLC16A2) and organic ion transporter-14 (SLCO1C1) at the blood-brain barrier. Endocrinology. 2008;149:6251-6261.
15. Mayerl S, Visser TJ, Bauer R, Darras VM, Heuer H. Consequences of brain-specific thyroid hormone deprivation im Mct8/Oatp1c1 double knockout mice. Thyroid. 2012;22:A-2 (abstract). 82nd Annual Meeting of the American Thyroid Association, Québec City, Canada.
16. Trajkovic-Arsic M, Muller J, Darras VM, et al. Impact of monocarboxylate transporter-8 deficiency on the hypothalamus-pituitary-thyroid axis in mice. Endocrinology. 2010;151:5053-5062.
17. Trajkovic-Arsic M, Visser TJ, Darras VM, et al. Consequences of monocarboxylate transporter 8 deficiency for renal transport and metabolism of thyroid hormones in mice. Endocrinology. 2010; 151:802-809.
18. Di Cosmo C, Liao XH, Dumitrescu AM, Philp NJ, Weiss RE, Refetoff S. Mice deficient inMCT8reveal a mechanism regulating thyroid hormone secretion. J Clin Invest. 2010;120:3377-3388.
19. Ramadan T, Camargo SM, Summa V, et al. Basolateral aromatic amino acid transporter TAT1 (Slc16a10) functions as an efflux pathway. J Cell Physiol. 2006;206:771-779.
20. Kim DK, Kanai Y, Chairoungdua A, Matsuo H, Cha SH, Endou H. Expression cloning of a Na-independent aromatic amino acid transporter with structural similarity to H-/monocarboxylate transporters. J Biol Chem. 2001;276:17221- 17228.
21. Kim DK, Kanai Y, Matsuo H, et al. The human T-type amino acid transporter-1: characterization, gene organization, and chromosomal location. Genomics. 2002;79:95-103.
22. Friesema EC, Jansen J, Jachtenberg JW, Visser WE, Kester MH, Visser TJ. Effective cellular uptake and efflux of thyroid hormone by human monocarboxylate transporter 10. Mol Endocrinol. 2008; 22:1357-1369.
23. Ramadan T, Camargo SM, Herzog B, Bordin M, Pos KM, Verrey F. Recycling of aromatic amino acids via TAT1 allows efflux of neutral amino acids via LAT2-4F2hc exchanger. Pflugers Arch. 2007;454:507-516.
24. Mariotta L, Ramadan T, Singer D, et al. T-type amino acid transporter TAT1 (Slc16a10) is essential for extracellular aromatic amino acid homeostasis control. J Physiol. 2012;590:6413-6424.
25. Friedrichsen S, Christ S, Heuer H, et al. Regulation of iodothyronine deiodinases in the Pax8+/-mouse model of congenital hypothyroidism. Endocrinology. 2003;144:777-784.
26. Wiersinga WM, Chopra IJ. Radioimmunoassay of thyroxine (T4), 3,5,3-triiodothyronine (T3), 3,3,5-triiodothyronine (reverse T3, rT3), and 3,3-diiodothyronine (T2). Methods Enzymol. 1982;84: 272-303.
27. Reyns GE, Janssens KA, Buyse J, Kuhn ER, Darras VM. Changes in thyroid hormone levels in chicken liver during fasting and refeeding. Comp Biochem Physiol B Biochem Mol Biol. 2002;132:239-245.
28. Pohlenz J, Maqueem A, Cua K, Weiss RE, Van Sande J, Refetoff S. Improved radioimmunoassay for measurement of mouse thyrotropin in serum: strain differences in thyrotropin concentration and thyrotroph sensitivity to thyroid hormone. Thyroid. 1999;9:1265-1271.
29. van Zeijl CJ, Surovtseva OV, Wiersinga WM, Boelen A, Fliers E. Transient hypothyroxinemia in juvenile glycoprotein hormone subunit B5 knock-out mice. Mol Cell Endocrinol. 2010;321:231-238.
30. Heuer H, SchaferMK,O'Donnell D, Walker P, Bauer K. Expression of thyrotropin-releasing hormone receptor 2 (TRH-R2) in the central nervous system of rats. J Comp Neurol. 2000;428:319-336.
31. Tashjian AH Jr., Barowsky NJ, Jensen DK. Thyrotropin releasing hormone: direct evidence for stimulation of prolactin production by pituitary cells in culture. Biochem Biophys Res Commun. 1971;43: 516-523.
32. Jacobs LS, Snyder PJ, Wilber JF, Utiger RD, Daughaday WH. Increased serum prolactin after administration of synthetic thyrotropin releasing hormone (TRH) in man. J Clin Endocrinol Metab. 1971;33:996-998.
33. Wirth EK, Sheu SY, Chiu-Ugalde J, et al. Monocarboxylate transporter 8 deficiency: altered thyroid morphology and persistent high triiodothyronine/ thyroxine ratio after thyroidectomy. Eur J Endocrinol. 2011;165:555-561.
34. Kim CS, Ying H, Willingham MC, Cheng SY. The pituitary tumortransforming gene promotes angiogenesis in a mouse model of follicular thyroid cancer. Carcinogenesis. 2007;28:932-939.
35. Smith VE, Read ML, Turnell AS, et al. PTTG-binding factor (PBF) is a novel regulator of the thyroid hormone transporter MCT8. Endocrinology. 2012;153:3526-3536.
36. Htwe TT, Karim N, Wong J, Jahanfar S, Mansur MA. Differential expression of galectin-3 in advancing thyroid cancer cells: a clue toward understanding tumour progression and metastasis. Singapore Med J. 2010;51:856-859.
37. Weiss RE, Murata Y, Cua K, Hayashi Y, Seo H, Refetoff S. Thyroid hormone action on liver, heart, and energy expenditure in thyroid hormone receptor -deficient mice. Endocrinology. 1998;139: 4945-4952.
38. Liao XH, Di Cosmo C, Dumitrescu AM, et al. Distinct roles of deiodinases on the phenotype of Mct8 defect: a comparison of eight different mouse genotypes. Endocrinology. 2011;152:1180-1191.
39. van der Deure WM, Peeters RP, Visser TJ. Molecular aspects of thyroid hormone transporters, including MCT8, MCT10, and OATPs, and the effects of genetic variation in these transporters. J Mol Endocrinol. 2009;44:1-11.
40. Medici M, van der Deure WM, Verbiest M, et al. A large-scale association analysis of 68 thyroid hormone pathway genes with serum TSH and FT4 levels. Eur J Endocrinol. 2011;164:781-788.